National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine
An antigen-specific DNA cancer vaccine consisting of the coding sequences of a signal peptide (pNGVL4a-Sig), a detox form of the human papillomavirus type 16 (HPV-16) antigen E7, and the heat shock protein 70 (HSP70). Upon administration, this vaccine may generate potent cytotoxic CD8(+) T-cell responses against E7-expressing tumor cells, resulting in tumor cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:plicamycin, plitidepsin, pneumococcal polyvalent vaccine, Pneumovax 23, pNGVL3-hICD vaccine
Next:PNP-expressing ovine atadenovirus FP253, Pnu-Imune 23, polifeprosan 20 with carmustine implant, Polo-like kinase 1 inhibitor GSK-461364, Polo-like kinase 1 inhibitor ON 01910.Na

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov